Progesterone Capsule
Product Images NDC 50090-6835

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 50090-6835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure 1)

A step plot chart showing the probability of hyperplasia over 36 months on medication. The x-axis represents time in months, with patient counts at intervals. The y-axis shows the probability of hyperplasia from 0 to 1. Three lines compare outcomes for Conjugated Estrogens Alone, Conjugated Estrogens Plus Micronized Progesterone (cyclical), and Placebo Only groups.*

FDA Label Image

Label Image (Lbl500906835)

Progesterone capsules 100 mg oral dosage form labeled by A-S Medication Solutions. The white capsule bottle label includes product and lot numbers, storage instructions to protect from excessive moisture and temperatures above 77 degrees Fahrenheit, and a warning not to use if allergic to peanuts. The package contains 10 capsules.*

FDA Label Image

Chemical Structure (Prog Structure)

Chemical structure of progesterone, showing the molecular arrangement of atoms and bonds characteristic to this steroid hormone.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.